Skip to main
CCJ

Cameco (CCJ) Stock Forecast & Price Target

Cameco (CCJ) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 29%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Cameco is a leading provider of uranium and nuclear services with top-tier production assets and a strong position in the growing nuclear sector demand. The company's strong long-term outlook is supported by potential production increases, a strong portfolio of assets and partnerships, and a squarely positioned role in the burgeoning uranium market. While risks such as the ongoing CRA transfer pricing dispute should be monitored, Cameco's strategic initiatives to promote diversity in leadership and sustainability efforts also make it an attractive investment option with strong social responsibility.

Bears say

Cameco is expected to continue facing challenges in the uranium market due to an oversupply of uranium and a lack of immediate demand for nuclear power. With a heavy dependence on the Westinghouse segment for revenue, regulatory and political risks could also impact the company's performance. Additionally, uncertainties surrounding production at McArthur River and the ongoing CRA transfer pricing dispute could add to the company's risks. Overall, with the potential for declining uranium prices and ongoing risks, it may be challenging for Cameco to achieve significant growth in the near future, leading to a negative outlook for the stock.

Cameco (CCJ) has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 29% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cameco and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cameco (CCJ) Forecast

Analysts have given Cameco (CCJ) a Buy based on their latest research and market trends.

According to 7 analysts, Cameco (CCJ) has a Buy consensus rating as of Jul 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $135.03, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $135.03, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cameco (CCJ)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.